Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10% of patients surviving longer than five years after diagnosis. But a new study from researchers at Washington University School of Medicine in St. Louis […]
Boosting T cells improves survival in mice with glioblastoma
